EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Handshake on a green background

AstraZeneca pays $160m for FibroGen's China subsidary

FibroGen, Inc. has announced the sale of its Chinese subsidiary to AstraZeneca, including the rights to roxadustat in China.

FDA fast-tracks Boehringer's NSCLC drug review

The FDA has granted priority review to zongertinib for non-small cell lung cancer (NSCLC).
Data

ABPI urges NHS to improve data access for pharma research

A new cross-industry report is calling for the UK’s NHS to design its health data infrastructure to meet the needs of pharma researchers.

FDA approves first at-home coeliac genetic test

A new at-home genetic test that assesses the risk of developing coeliac disease has received approval from US regulators.

Kennedy secures US health role despite backlash

Robert F. Kennedy Jr has been confirmed as the US Secretary of Health and Human Services following a 52-48 Senate vote.
Britain

ABPI reveals data on UK’s life sciences competitive edge

A new survey from the ABPI has revealed a surge in apprenticeships, placements and global research collaborations in the UK pharma space.
Handshake on a green background

Novartis to acquire Anthos Therapeutics for $925m

To boost its cardiovascular pipeline, Novartis has announced the acquisition of the company it co-founded with Blackstone Life Sciences.

Lupus nephritis drug delivers promising results, says Roche

Obinutuzumab could reshape the treatment of lupus nephritis, a life-threatening complication of lupus that has long lacked effective options.